C Diff Drug Stewardship

C Diff Drug Stewardship

824 bookmarks
Custom sorting
Identifying-and-Addressing-Health-Disparities-in-Antimicrobial-Use
Identifying-and-Addressing-Health-Disparities-in-Antimicrobial-Use
Structural-racism-and-systemic-injustices-inhibit-the-ability-to-have-equitable-healthcare-also-negatively-impacts-antimicrobial-stewardship-according-to-Jacinda
·pharmacypracticenews.com·
Identifying-and-Addressing-Health-Disparities-in-Antimicrobial-Use
Closing-the-Safety-Gap-in-Outpatient-ABX-Stewardship
Closing-the-Safety-Gap-in-Outpatient-ABX-Stewardship
Outpatient-AMS-efforts-at-many-medical-centers-took-a-back-seat-during-the-COVID-19-pandemic-but-now-is-a-good-time-to-revamp-them-presenters-said-at-the-2022-ACCP
·pharmacypracticenews.com·
Closing-the-Safety-Gap-in-Outpatient-ABX-Stewardship
How Bad is Antibiotic Resistance Today? An Interview with Dr. David
How Bad is Antibiotic Resistance Today? An Interview with Dr. David
A recent article in USA Today proclaimed that we are *this* far away from no longer having working antibiotics, a cataclysmic development that would pose "an existential threat for modern medicine."
·news.google.com·
How Bad is Antibiotic Resistance Today? An Interview with Dr. David
Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017-2019 - PubMed
Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017-2019 - PubMed
In the German university hospital setting, monthly ward-level carbapenem consumption seems to increase the HAHO-CDI incidence density predominantly on haematological-oncological wards. Furthermore, other patient-specific factors seem to be equally important to control HAHO-CDI.
·pubmed.ncbi.nlm.nih.gov·
Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017-2019 - PubMed
Prophylactic antibiotics for massive endoprostheses in orthopaedic oncology - PubMed
Prophylactic antibiotics for massive endoprostheses in orthopaedic oncology - PubMed
The recently published Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY) trial found no benefit in extending antibiotic prophylaxis from 24 hours to five days after endoprosthetic reconstruction for lower limb bone tumours. PARITY is the first randomized controlled trial in orthopaedic onco …
·pubmed.ncbi.nlm.nih.gov·
Prophylactic antibiotics for massive endoprostheses in orthopaedic oncology - PubMed
Safe use of proton-pump inhibitors - PubMed
Safe use of proton-pump inhibitors - PubMed
Proton pump inhibitors (PPIs) are one of the most commonly prescribed drug groups in developed countries. Their approved indications include gastroesophageal reflux disease, peptic ulcer disease, and prophylaxis against NSAID-induced gastroenteropathy in specific scenarios. Since their introduction …
·pubmed.ncbi.nlm.nih.gov·
Safe use of proton-pump inhibitors - PubMed
Identifying-Racial-Disparities-In-Antibiotic-Prescribing
Identifying-Racial-Disparities-In-Antibiotic-Prescribing
Racial-disparities-continue-to-impede-antimicrobial-stewardship-among-antibiotic-prescribing-for-patients-with-CDI-and-Candidemia-according-to-according-to-Jacinda
·idse.net·
Identifying-Racial-Disparities-In-Antibiotic-Prescribing
Inappropriate use of proton pump inhibitor among elderly patients in British Columbia: what are the long-term adverse events? - PubMed
Inappropriate use of proton pump inhibitor among elderly patients in British Columbia: what are the long-term adverse events? - PubMed
This study revealed a high prevalence of PPI use among elderly populations in BC, Canada. The overutilization of PPIs is often a result of failure to re-evaluate the need for continuation of therapy. Published studies identified signals of serious harm from long-term PPI exposure. Healthcare provide …
·pubmed.ncbi.nlm.nih.gov·
Inappropriate use of proton pump inhibitor among elderly patients in British Columbia: what are the long-term adverse events? - PubMed
Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021) - BMC Infectious Diseases
Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021) - BMC Infectious Diseases
Background Antibiotic usage and antibiotic resistance (ABR) patterns changed during the COVID-19 pandemic. Inadequate empiric antibiotic therapy (IET) is a significant public health problem and contributes to ABR. We evaluated factors associated with IET before and during the COVID-19 pandemic to determine the impact of the pandemic on antibiotic management. Methods This multicenter, retrospective cohort analysis included hospitalized US adults who had a positive bacterial culture (specified gram-positive or gram-negative bacteria) from July 2019 to October 2021 in the BD Insights Research Database. IET was defined as antibacterial therapy within 48 h that was not active against the bacteria. ABR results were based on susceptibility testing and reports from local facilities. Multivariate analysis was used to identify risk factors associated with IET in patients with any positive bacterial culture and ABR-positive cultures, including multidrug-resistant (MDR) bacteria. Results Of 278,344 eligible patients in 269 hospitals, 56,733 (20.4%) received IET; rates were higher in patients with ABR-positive (n = 93,252) or MDR-positive (n = 39,000) cultures (34.9% and 45.0%, respectively). Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)-positive patients had significantly higher rates of IET (25.9%) compared with SARS-CoV-2-negative (20.3%) or not tested (19.7%) patients overall and in the ABR and MDR subgroups. Patients with ABR- or MDR-positive cultures had more days of therapy and longer lengths of stay. In multivariate analyses, ABR, MDR, SARS-CoV-2-positive status, respiratory source, and prior admissions were identified as key IET risk factors. Conclusions IET remained a persistent problem during the COVID-19 pandemic and occurred at higher rates in patients with ABR/MDR bacteria or a co-SARS-CoV-2 infection.
·news.google.com·
Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021) - BMC Infectious Diseases
Antibiotic perturbations to the gut microbiome
Antibiotic perturbations to the gut microbiome
Nature Reviews Microbiology - In this Review, Fishbein, Mahmud and Dantas discuss factors that influence restructuring of the gut microbiome on antibiotic exposure, and they explore promising...
·news.google.com·
Antibiotic perturbations to the gut microbiome
Taking Doxycycline for a Sinus Infection
Taking Doxycycline for a Sinus Infection
Doxycycline is a commonly prescribed antibiotic for bacterial sinus infections. Learn more about how it works and what to expect when you start taking it.
·news.google.com·
Taking Doxycycline for a Sinus Infection
C. Difficile Infection within 6 Months before TKA Is Associated with Increased Short-Term Complications - PubMed
C. Difficile Infection within 6 Months before TKA Is Associated with Increased Short-Term Complications - PubMed
A history of Clostridium difficile infection (CDI) before total knee arthroplasty (TKA) may be a marker for poor patient health and could be used to identify patients with higher risks for complications after TKA. We compared the frequency of 90-day postoperative CDI, complications, readmissi …
·pubmed.ncbi.nlm.nih.gov·
C. Difficile Infection within 6 Months before TKA Is Associated with Increased Short-Term Complications - PubMed
Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to Clostridioides difficile toxin-mediated mitochondrial damage - PubMed
Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to Clostridioides difficile toxin-mediated mitochondrial damage - PubMed
Clostridioides difficile damages the colonic mucosa through the action of two potent exotoxins. Factors shaping C. difficile pathogenesis are incompletely understood but are likely due to the ecological factors in the gastrointestinal ecosystem, mucosal immune responses, and environmen …
·pubmed.ncbi.nlm.nih.gov·
Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to Clostridioides difficile toxin-mediated mitochondrial damage - PubMed
CHOP Researchers Reveal How NSAIDs Worsen C. difficile Infections
CHOP Researchers Reveal How NSAIDs Worsen C. difficile Infections
Why do nonsteroidal anti-inflammatory drugs (NSAIDs) exacerbate gastrointestinal infections by Clostridioides difficile, the leading cause of antibiotic-associated diarrhea worldwide? In a new paper published in Science Advances, researchers at Children's Hospital of Philadelphia (CHOP) have begun to answer that question, showing that NSAIDs disrupt the mitochondria of cells lining the colon, sensitizing them to damage by pathogenic toxins.
·news.google.com·
CHOP Researchers Reveal How NSAIDs Worsen C. difficile Infections
P074 Comparative Risk of Clostridioides Difficile Infection in Vedolizumab vs anti-TNFa Agents in Biologic-Naïve Patients With Ulcerative Colitis - PubMed
P074 Comparative Risk of Clostridioides Difficile Infection in Vedolizumab vs anti-TNFa Agents in Biologic-Naïve Patients With Ulcerative Colitis - PubMed
Our study did not identify an increased risk of CDI associated with vedolizumab vs anti-TNFa agents after controlling for UC severity. We hope that these findings will reassure UC providers considering vedolizumab as a first-line biologic agent in the context of gastrointestinal infectious risks.
·pubmed.ncbi.nlm.nih.gov·
P074 Comparative Risk of Clostridioides Difficile Infection in Vedolizumab vs anti-TNFa Agents in Biologic-Naïve Patients With Ulcerative Colitis - PubMed
Diagnostic stewardship: what impacts antibiotics use? - PubMed
Diagnostic stewardship: what impacts antibiotics use? - PubMed
Diagnostic stewardship decreases unnecessary antibiotic use in a way that is different from and complementary to antibiotic stewardship. Further studies are needed to quantify the full impact on antibiotic use and resistance. Future considerations should be to institutionalize diagnostic stewardship …
·pubmed.ncbi.nlm.nih.gov·
Diagnostic stewardship: what impacts antibiotics use? - PubMed
Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset Clostridioides difficile infection (HO-CDI) rates: A diagnostic stewardship intervention - PubMed
Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset Clostridioides difficile infection (HO-CDI) rates: A diagnostic stewardship intervention - PubMed
Misclassification of iClostridioides difficile/i colonization as hospital-onset iC. difficile/i infection (HO-CDI) can lead to unnecessary treatment of patients and substantial financial penalties for hospitals. We successfully implemented mandatory iC. difficile/i PCR testing approval a …
·pubmed.ncbi.nlm.nih.gov·
Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset Clostridioides difficile infection (HO-CDI) rates: A diagnostic stewardship intervention - PubMed
Diagnostic stewardship: what impacts antibiotics use? - PubMed
Diagnostic stewardship: what impacts antibiotics use? - PubMed
Diagnostic stewardship decreases unnecessary antibiotic use in a way that is different from and complementary to antibiotic stewardship. Further studies are needed to quantify the full impact on antibiotic use and resistance. Future considerations should be to institutionalize diagnostic stewardship …
·pubmed.ncbi.nlm.nih.gov·
Diagnostic stewardship: what impacts antibiotics use? - PubMed
Estimating the cost of inappropriate antibiotic prophylaxis prior to dental procedures - PubMed
Estimating the cost of inappropriate antibiotic prophylaxis prior to dental procedures - PubMed
Inappropriate dental antibiotic prescriptions to prevent infective endocarditis in the United States results in ∼$31 million in excess costs to the healthcare system and patients. This includes out-of-pocket costs ($20.5 million), drug costs ($2.69 million) and adverse event costs (eg, Clostridio …
·pubmed.ncbi.nlm.nih.gov·
Estimating the cost of inappropriate antibiotic prophylaxis prior to dental procedures - PubMed
NFID on Twitter
NFID on Twitter
“#Antibiotics make you 7x more likely to get a #Cdiff infection—learn how to help protect yourself at https://t.co/Hx0mpJWb7f and https://t.co/YbavFZUqvO #BeAntibioticsAware #SeeCdiff @PeggyFund”
·twitter.com·
NFID on Twitter
Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher Clostridioides difficile infection rate - PubMed
Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher Clostridioides difficile infection rate - PubMed
Although prior PPI use might not have significant impact on clinical course and mortality of SARS-CoV-2 infection, it may predispose development of complications like higher occurrence of Cdiff, and thus substantially impact the course of treatment.
·pubmed.ncbi.nlm.nih.gov·
Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher Clostridioides difficile infection rate - PubMed
Pharmacists and Infection Preventionists: Collaboration on Antimicrobial Stewardship
Pharmacists and Infection Preventionists: Collaboration on Antimicrobial Stewardship
A presentation at the APIC 2023 annual conference was about reducing the unnecessary treatment of asymptomatic bacteria, and the presenters shared some of the successful strategies they have implemented at their hospital.
·infectioncontroltoday.com·
Pharmacists and Infection Preventionists: Collaboration on Antimicrobial Stewardship